You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Retinal Telangiectasis in Facioscapulohumeral Muscular Dystrophy With Deafness

E. B. Gurwin, MD; R. B. Fitzsimons, FRACP; K. S. Sehmi, FRPS; A. C. Bird, MD

Arch Ophthalmol. 1985;103(11):1695-1700.


Abstract

• A 22-year-old patient with newly diagnosed facioscapulohumeral (FSH) muscular dystrophy had a macular lesion in her right eye and poor central vision, which had been present since early childhood. Fluorescein angiographic examination revealed bilateral peripheral vessel closure, peripheral retinal telangiectasis, and hyperfluorescence in both foveae. This widespread vascular abnormality was deemed responsible for her macular disease. Her mother, brother, and sister, all of whom are affected by varying degrees of FSH muscular dystrophy and clinical deafness, also have abnormal retinal vasculature, as determined by fluorescein angiography. However, none had related visual symptoms and two showed no ophthalmoscopic evidence of vascular abnormalities. In young patients with unexplained retinal vascular lesions, the diagnosis of FSH muscular dystrophy should be considered. Similarly, young patients with FSH muscular dystrophy should be examined for sight-threatening and potentially treatable vascular retinopathy.



Author Affiliations

From the Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital (Drs Gurwin, Fitzsimons, Sehmi, and Bird), and the Department of Pediatrics, Hammersmith Hospital (Dr Fitzsimons), London.


Footnotes

Accepted for publication July 2, 1985.

Reprint requests to the Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, England (Dr Bird).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neovascular Glaucoma From Advanced Coats Disease as the Initial Manifestation of Facioscapulohumeral Dystrophy in a 2-Year-Old Child
Shields et al.
Arch Ophthalmol 2007;125:840-842.
FULL TEXT  

Eye and Kidney: From Clinical Findings to Genetic Explanations
Izzedine et al.
J. Am. Soc. Nephrol. 2003;14:516-529.
FULL TEXT  

Cerebroretinal vasculopathy mimicking a brain tumor: A case of a rare hereditary syndrome
Weil et al.
Neurology 1999;53:629-629.
ABSTRACT | FULL TEXT  

Facioscapulohumeral Muscular Dystrophy in Early Childhood
Brouwer et al.
Arch Neurol 1994;51:387-394.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.